Antimicrobial stewardship and prevention and control of antimicrobial resistance in healthcare institutions: a discussion based on the <i>National Action Plan to Combat Antimicrobial Resistance (2022-2025)</i>_West China Medical Journal

Authors：

XIAO Guirong ¹ ,  ZONG Zhiyong ²

1. Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
2. Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

ZONG Zhiyong, Email: zongzhiy@scu.edu.cn

Keywords：

Antimicrobial resistance; action plan; antimicrobial stewardship

DOI：

10.7507/1002-0179.202302037

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

In October 2022, thirteen government departments including the National Health Commission jointly issued the National Action Plan to Combat Antimicrobial Resistance (2022-2025) to proactively address challenges of antimicrobial resistance. In support of the implementation of the National Action Plan in healthcare institutions, the authors put forward following suggestions for prevention and control measures: strengthen construction of supporting systems and disciplines, enhance prevention and control of hospital-acquired infections caused by drug-resistant bacteria, promote precision diagnosis and treatment through diagnostic stewardship, advance rational drug use by performing prescription review, carry out universal and targeted training, establish clinical decision support systems using information technology, improve monitoring and evaluation systems, and enhance multi-source data fusion and application.

Citation： XIAO Guirong, ZONG Zhiyong. Antimicrobial stewardship and prevention and control of antimicrobial resistance in healthcare institutions: a discussion based on the National Action Plan to Combat Antimicrobial Resistance (2022-2025). West China Medical Journal, 2023, 38(3): 321-325. doi: 10.7507/1002-0179.202302037 Copy

1.	国家卫生健康委员会合理用药专家委员会. 2021 年全国细菌耐药监测报告(简要版). 北京: 全国细菌耐药监测网, 2023.
2.	国家卫生健康委员会. 遏制微生物耐药国家行动计划(2022-2025年). 中国感染控制杂志, 2022, 21(12): 1264-1266.
3.	Tang G, Huang L, Zong Z. Impact of infectious disease consultation on clinical management and outcome of patients with bloodstream infection: a retrospective cohort study. Sci Rep, 2017, 7(1): 12898.
4.	Ishikane M, Hayakawa K, Kutsuna S, et al. The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years. PLoS One, 2019, 14(4): e0215996.
5.	Hasegawa S, Kakiuchi S, Tholany J, et al. Impact of infectious diseases consultation among patients with infections caused by gram-negative rod bacteria: a systematic literature review and meta-analysis. Infect Dis (Lond), 2022, 54(8): 618-621.
6.	Pliakos EE, Ziakas PD, Mylonakis E. Economic analysis of infectious disease consultation for Staphylococcus aureus bacteremia among hospitalized patients. JAMA Netw Open, 2022, 5(9): e2234186.
7.	Zhao H, Wei L, Li H, et al. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis, 2021, 21(6): 847-857.
8.	Taxifulati Y, Wushouer H, Fu M, et al. Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing city, China, 2015-2018. BMC Health Serv Res, 2021, 21(1): 832.
9.	Zhao H, Wang S, Meng R, et al. Appropriateness of antibiotic prescriptions in Chinese primary health care and the impact of the COVID-19 pandemic: a typically descriptive and longitudinal database study in Yinchuan city. Front Pharmacol, 2022, 13: 861782.
10.	Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the american college of physicians and the centers for disease control and prevention. Ann Intern Med, 2016, 164(6): 425-434.
11.	施毅, 刘又宁, 张波, 等. 肺念珠菌病. 中国感染与化疗杂志, 2011, 11(2): 114-118.
12.	Meena DS, Kumar D. Candida pneumonia: an innocent bystander or a silent killer?. Med Princ Pract, 2022, 31(1): 98-102.
13.	Terraneo S, Ferrer M, Martín-Loeches I, et al. Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clin Microbiol Infect, 2016, 22(1): 94.e1-94.e8.
14.	Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med, 2011, 183(1): 96-128.
15.	汪皖青, 郑爽, 侯欢, 等. 不同地区两家三甲医院医生和患者国家药品集中采购政策认知现状及药学需求调查研究. 医药导报, 2022, 41(10): 1557-1563.
16.	童荣生, 赵杰, 王明贵, 等. 医疗机构抗菌药物集中带量采购管理专家共识. 医药导报, 2023, 42(1): 1-5.

1. 国家卫生健康委员会合理用药专家委员会. 2021 年全国细菌耐药监测报告(简要版). 北京: 全国细菌耐药监测网, 2023.
2. 国家卫生健康委员会. 遏制微生物耐药国家行动计划(2022-2025年). 中国感染控制杂志, 2022, 21(12): 1264-1266.
3. Tang G, Huang L, Zong Z. Impact of infectious disease consultation on clinical management and outcome of patients with bloodstream infection: a retrospective cohort study. Sci Rep, 2017, 7(1): 12898.
4. Ishikane M, Hayakawa K, Kutsuna S, et al. The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years. PLoS One, 2019, 14(4): e0215996.
5. Hasegawa S, Kakiuchi S, Tholany J, et al. Impact of infectious diseases consultation among patients with infections caused by gram-negative rod bacteria: a systematic literature review and meta-analysis. Infect Dis (Lond), 2022, 54(8): 618-621.
6. Pliakos EE, Ziakas PD, Mylonakis E. Economic analysis of infectious disease consultation for Staphylococcus aureus bacteremia among hospitalized patients. JAMA Netw Open, 2022, 5(9): e2234186.
7. Zhao H, Wei L, Li H, et al. Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study. Lancet Infect Dis, 2021, 21(6): 847-857.
8. Taxifulati Y, Wushouer H, Fu M, et al. Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing city, China, 2015-2018. BMC Health Serv Res, 2021, 21(1): 832.
9. Zhao H, Wang S, Meng R, et al. Appropriateness of antibiotic prescriptions in Chinese primary health care and the impact of the COVID-19 pandemic: a typically descriptive and longitudinal database study in Yinchuan city. Front Pharmacol, 2022, 13: 861782.
10. Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the american college of physicians and the centers for disease control and prevention. Ann Intern Med, 2016, 164(6): 425-434.
11. 施毅, 刘又宁, 张波, 等. 肺念珠菌病. 中国感染与化疗杂志, 2011, 11(2): 114-118.
12. Meena DS, Kumar D. Candida pneumonia: an innocent bystander or a silent killer?. Med Princ Pract, 2022, 31(1): 98-102.
13. Terraneo S, Ferrer M, Martín-Loeches I, et al. Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clin Microbiol Infect, 2016, 22(1): 94.e1-94.e8.
14. Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med, 2011, 183(1): 96-128.
15. 汪皖青, 郑爽, 侯欢, 等. 不同地区两家三甲医院医生和患者国家药品集中采购政策认知现状及药学需求调查研究. 医药导报, 2022, 41(10): 1557-1563.
16. 童荣生, 赵杰, 王明贵, 等. 医疗机构抗菌药物集中带量采购管理专家共识. 医药导报, 2023, 42(1): 1-5.

Next Article
Implementation of WHO Core Competencies of Infection Prevention and Control Practitioners – a practical approach

West China Medical Journal

Antimicrobial stewardship and prevention and control of antimicrobial resistance in healthcare institutions: a discussion based on the National Action Plan to Combat Antimicrobial Resistance (2022-2025)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content